BE899937A - Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation comme medicaments. - Google Patents

Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation comme medicaments.

Info

Publication number
BE899937A
BE899937A BE1/011042A BE1011042A BE899937A BE 899937 A BE899937 A BE 899937A BE 1/011042 A BE1/011042 A BE 1/011042A BE 1011042 A BE1011042 A BE 1011042A BE 899937 A BE899937 A BE 899937A
Authority
BE
Belgium
Prior art keywords
medicaments
alkyl
novel
preparation
dihydropyridine derivatives
Prior art date
Application number
BE1/011042A
Other languages
English (en)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of BE899937A publication Critical patent/BE899937A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Abstract

L'invention concerne les 1,4-dihydropyridines de formule (I) dans laquelle R1 est l'hydrogène, cycloalkyle ou alkyle, R2 et R'2 sont hydrogène ou alkyle, R3 est alkyle, -AR4 est hydroxy, alcoxy, acyloxy, amino substitué ou une amine cyclique, A est alkylène et Q un système cyclique condensé insaturé contenant au moins 2 hétéro-atomes différents, et les sels d'ammonium des composés dans lesquels R4 est un groupe amino tertiaire. Ces composés peuvent etre utilisés comme médicaments, notamment comme antagonistes du calcium.
BE1/011042A 1983-06-21 1984-06-18 Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation comme medicaments. BE899937A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH339483 1983-06-21

Publications (1)

Publication Number Publication Date
BE899937A true BE899937A (fr) 1984-12-18

Family

ID=4255028

Family Applications (1)

Application Number Title Priority Date Filing Date
BE1/011042A BE899937A (fr) 1983-06-21 1984-06-18 Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation comme medicaments.

Country Status (15)

Country Link
JP (1) JPS6013789A (fr)
AU (1) AU2956484A (fr)
BE (1) BE899937A (fr)
CH (1) CH663616A5 (fr)
DE (1) DE3421992A1 (fr)
DK (1) DK299784A (fr)
FR (1) FR2549058B1 (fr)
GB (1) GB2142021B (fr)
IL (1) IL72152A0 (fr)
IT (1) IT1199143B (fr)
LU (1) LU85423A1 (fr)
NL (1) NL8401932A (fr)
SE (1) SE8403268L (fr)
WO (1) WO1985000169A1 (fr)
ZA (1) ZA844725B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4755512A (en) * 1984-04-11 1988-07-05 Bristol-Myers Company Pharmaceutically useful dihydropyridinyldicarboxylate amides and esters incorporating arylpiperazinylalkyl moities
HUT39179A (en) * 1984-12-10 1986-08-28 Sandoz Ag Process for production of derivatives of 1,4-dihydro-piridin
EP0191724A3 (fr) * 1985-01-15 1986-12-03 Sandoz Ag 1,4-Dihydropyridines, leur procédé de préparation et les compositions pharmaceutiques les contenant
US4659717A (en) * 1985-08-21 1987-04-21 Eli Lilly And Company Dihydropyridines useful in the treatment of angina and stroke
EP0222702A3 (fr) * 1985-11-06 1988-01-07 Ciba-Geigy Ag Dérivés carbonyliques basiques
US4868181A (en) * 1986-08-04 1989-09-19 E. I. Du Pont De Nemours And Company 1,4-dihydropyridine derivatives with calcium agonist and alpha1 -antagonist activity
WO1988007525A1 (fr) * 1987-03-27 1988-10-06 Byk Gulden Lomberg Chemische Fabrik Gmbh Enantiomeres de 1,4-dihydropyridine
WO1988007531A1 (fr) * 1987-03-27 1988-10-06 Byk Gulden Lomberg Chemische Fabrik Gmbh Nouveaux composes optiquement actifs
JPH03500647A (ja) * 1987-10-27 1991-02-14 ビイク　グルデン　ロンベルク　ヒエーミツシエ　フアブリーク　ゲゼルシヤフト　ミツト　ベシユレンクテル　ハフツング 新規ピロリジン
JPH10205466A (ja) * 1997-01-23 1998-08-04 Mitsubishi Heavy Ind Ltd スクロール型流体機械

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2949464A1 (de) * 1978-12-18 1980-06-26 Sandoz Ag Benzoxadiazole und benzothiadiazole, ihre herstellung und verwendung
DE3022030A1 (de) * 1980-06-12 1981-12-17 Bayer Ag, 5090 Leverkusen 4-thiazol- bzw. 4-imidazol-substituierte, 1,4-dihydropyridine, verfahren zu deren herstellung sowie diese enthaltende arzneimittel
JPS57175165A (en) * 1981-04-21 1982-10-28 Tokyo Tanabe Co Ltd Novel 1,4-dihydropyridine-3,5-dicarboxylic diester derivative and its salt
DE3208628A1 (de) * 1982-03-10 1983-09-22 Bayer Ag, 5090 Leverkusen Neue verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
EP0094159B1 (fr) * 1982-05-10 1990-03-14 Takeda Chemical Industries, Ltd. Dérivés de la dihydropyridine, leur préparation et leur application

Also Published As

Publication number Publication date
NL8401932A (nl) 1985-01-16
IT8448415A0 (it) 1984-06-19
GB8415523D0 (en) 1984-07-25
GB2142021B (en) 1987-07-15
SE8403268D0 (sv) 1984-06-19
IT1199143B (it) 1988-12-30
FR2549058B1 (fr) 1988-02-19
SE8403268L (sv) 1984-12-22
DK299784D0 (da) 1984-06-19
DE3421992A1 (de) 1985-01-03
IL72152A0 (en) 1984-10-31
WO1985000169A1 (fr) 1985-01-17
AU2956484A (en) 1985-01-03
FR2549058A1 (fr) 1985-01-18
LU85423A1 (fr) 1985-03-26
ZA844725B (en) 1986-02-26
GB2142021A (en) 1985-01-09
CH663616A5 (de) 1987-12-31
DK299784A (da) 1984-12-22
JPS6013789A (ja) 1985-01-24

Similar Documents

Publication Publication Date Title
KR870000332A (ko) 이미다조헤테로 사이클릭 화합물의 제조방법
BE901274A (fr) Nouveaux derives d'amines cycliques, leur preparation et leur utilisation comme medicaments.
DE3370478D1 (en) Isoquinolinesulfonamide derivatives and process for the preparation thereof
ES2065880T3 (es) Proteina quimicamente modificada y obtencion de la misma.
EA199800051A1 (ru) Производные бензамида и их применение в качестве антагонистов вазопрессина
FI843765L (fi) Kramp motverkande sulfamatderivat.
BE899937A (fr) Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation comme medicaments.
ES2045152T3 (es) Derivados de lipidos, su preparacion y uso.
HUP9800087A2 (hu) Alkoxi-imino-ecetsav-amidok, e vegyületeket tartalmazó növényvédő szerek, valamint eljárás kártevők leküzdésére, továbbá e vegyületek előállítására
BE904796A (fr) Nouveaux derives du morphinane et de la morphine, leur preparation, leur application comme medicaments et les compositions pharmaceutiques les contenant.
ES8301972A1 (es) Procedimiento para la obtencion de n-oxidos de compuestos den-oxaciclil-alquil-piperidil-diaza
DE69031913T2 (de) Antivirale mittel
KR910016695A (ko) 4-(아미노메틸) 피페리딘 유도체, 그의 제조방법 및 치료에의 이용
ATE73447T1 (de) Verbindung auf basis von chinolin, verfahren zur herstellung und antikrebsmittel enthaltend diese verbindung als pharmakologisch wirksame komponente.
KR860000269A (ko) 칼슘길항성의 1-[비스-(4-플루오로페닐)-메틸-4-(3-페닐-2-프로페닐)-헥사하이드로-1h-1, 4-디아제핀의 제조방법및 이것을 함유한 약학적조성물
BR9809643A (pt) Compostos heterocìclicos, seu processo de preparo e as composições farmacêuticas que os contêm
KR870010034A (ko) 3-카바모일-4-하이드록시-쿠마린 및 이의 제조방법
FR2419935A1 (fr) Analogues de la prostaglandine i2 et compositions pharmaceutiques les contenant
DE3788149T2 (de) Prostazyklin-(PGI2)-Analoge.
FR2591599B1 (fr) Nouvelles anthracyclines et medicaments les contenant
BE905397A (fr) Nouveaux ethers allyliques bicycliques, leur preparation et leur utilisation comme anti-fongiques et fongicides.
KR910006310A (ko) 신규한 나프탈렌 및 테트라히드로 나프탈렌 치환된 겜-디포스포네이트 유도체
BE900874A (fr) Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation en therapeutique comme medicaments.
BE902461A (fr) Diphosphonites cycliques, leur preparation et applications.
ATE70842T1 (de) Bakterizide pyridobenzothiazinderivate mit langer wirkungsdauer.

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: SANDOZ S.A.

Effective date: 19880630